“…Sections were incubated in 50 μg mL −1 proteinase K (Roche, Lewes, UK) in PBS pH 7.4 for 15 min at 37°C prior to immunolabelling with CD3, CD8 (C8/144B), CD68 (KP1), GFAP (astrocytes), CD163 (GH1/61; Santa Cruz Biotechnology Inc, California, USA) and CCR5 (3A9; Pharmingen, Oxford, UK). Sections were heated at full power (800 W) for 5 min fully immersed in Vector unmasking solution (Vector Laboratories, Peterborough, UK) previously heated to 96°C for immunolabelling of CD4 (H370, Santa Cruz, Autogen Bioclear, Wiltshire), CNPase1 (oligodendrocytes, 11-5B) (Neomarkers), FF1 (phosphorylated neurofilaments, Dr E Gardner, William Paterson University, USA) or 10 mM citrate buffer (pH 6), KK41 (SIV gp41, Kent et al 1991), KK75 (SIV Nef, Arnold et al 1999). Sections were treated using a MenaPath pressurised antigen access unit (125°C 30 s, 90°C 10 s, Access Super solution) for immunolabelling with iba-1 (microglia; Menarini Diagnostics).…”